Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
83%(5 trials)

Phase Distribution

Ph not_applicable
1
11%
Ph early_phase_1
1
11%
Ph phase_1
2
22%
Ph phase_3
1
11%
Ph phase_4
4
44%

Phase Distribution

3

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting1
Active, not recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 12 (22.2%)
Phase 31 (11.1%)
Phase 44 (44.4%)
N/A1 (11.1%)

Trials by Status

recruiting111%
active_not_recruiting111%
completed667%
suspended111%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_1

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

NCT07063342
active_not_recruitingearly_phase_1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

NCT05880862
suspendednot_applicable

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

NCT03709992
completedphase_3

Anticholinergic vs. Botox Comparison Study

NCT01166438
completedphase_1

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

NCT02831231
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07063342Phase 1

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

Recruiting
NCT05880862Early Phase 1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

Active Not Recruiting
NCT03709992Not Applicable

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Suspended
NCT01166438Phase 3

Anticholinergic vs. Botox Comparison Study

Completed
NCT02831231Phase 1

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

Completed
NCT01922115Phase 4

The Effect of Anticholinergics on Cognitive Function in the Elderly

Completed
NCT00863551Phase 4

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Completed
NCT01178827Phase 4

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial

Completed
NCT01089751Phase 4

Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9